GREAT LAKES BAY VENTURE — Full Portfolio
2 tracked investments · listed companies and verified rows first
BiotechCambridge, US
Marshall H. Woodworth(Executive Officer)Hyung Heon Kim(Executive Officer, Director)P. Kent Hawryluk(Board of Directors Member)Margaret McShane(Executive Officer)Charles Bisgaier(Executive Officer)Mina Sooch(Executive Officer)
Board seatKenneth Kousky· per SEC Form D · $12.5M raise · filed Mar 2017
First-in-class optogenetic therapy for retinal diseases; acquired by Allergan.
BiotechAnn Arbor, US
Terry Cross(Director)Cam Gallagher(Director)Sean Ainsworth(Executive Officer, Director)George Lasezkay(Director)Kenneth Kousky(Director)
Board seatKenneth Kousky· per SEC Form D · $5M raise · filed Oct 2015
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.